Combined c-MET and MEK Inhibition Results in a Synergistic sorted by
relevance

Admin30.08.2021

Combined c-MET and MEK Inhibition Results in a Synergistic

1007
Admin20.08.2021

Combined c-MET and MEK Inhibition Results in a Synergistic

709
Admin19.07.2021

Combined HDAC and MEK inhibition results in synergistic

4000
Admin29.07.2021

Combined c-MET and MEK inhibition results in apoptosis in

5504
Admin04.09.2021

Therapeutic potential of combined BRAF/MEK blockade in

4306
Admin25.07.2021

Combined MEK and BCL-2/XL Inhibition Is Effective in High

700
Admin08.08.2021

Combined HDAC and MEK inhibition results in synergistic

1504
Admin07.10.2021

HDAC Inhibition Overcomes Acute Resistance to MEK

Admin24.07.2021

Combination of pan-RAF and MEK inhibitors in NRAS mutant

9806
Admin14.08.2021

Drug combination effects judged by combined synergy

84010
Admin05.09.2021

SHP2 Inhibition Abrogates MEK inhibitor Resistance in

1101
Admin01.08.2021

ADAM-10 and -17 regulate endometriotic cell migration via

7001
Admin09.09.2021

(PDF) Mutant HRAS as novel target for MEK and mTOR inhibitors

Admin12.08.2021

Genomic Status of MET Potentiates Sensitivity to MET and

59010
Admin18.07.2021

SHP2 Inhibition Abrogates MEK inhibitor Resistance in

6607
Admin07.09.2021

MDM2 antagonists synergize broadly and robustly with

3305
Admin29.08.2021

(PDF) MEK/MELK inhibition and blood-brain barrier

38010
Admin22.08.2021

Combination of pan-RAF and MEK inhibitors in NRAS mutant

2504
Admin30.09.2021

(PDF) ADAM17-dependent c-MET-STAT3 signaling mediates

809
Admin16.08.2021

(PDF) Combination treatment strategy for pancreatic cancer

4500
Admin13.07.2021

Activation of an early feedback survival loop involving

2103